Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

36
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
36
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

38
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
38
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.8K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.8K
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

54
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
54
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

38
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
38
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

48
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of a blended care intervention in physiotherapy with exercise and education for patients with hip or knee osteoarthritis (SmArt-E): A multicentre pragmatic randomized controlled trial.

Osteoarthritis and cartilage·2026
Same author

Exploring utilisation of knee and hip osteoarthritis healthcare services and its predictors: a scoping review.

BMJ open·2026
Same author

Greatest of All Time: Development of a Ranking System to Determine the Most Successful Olympic and World Championship Runners Since 1896.

Sports medicine (Auckland, N.Z.)·2026
Same author

Truncated N-glycans destabilize POMT1 and POMT2 but do not limit cellular O-mannosylation in HEK293 cells.

Molecular genetics and metabolism·2026
Same author

L-fucose supplementation in a patient with global hypofucosylation and a mono-allelic variant in SLC35C1: Clinical improvement and assessment of biomarkers.

Molecular genetics and metabolism·2026
Same author

Establishing an auxin-inducible GFP nanobody-based acute protein knockdown system to mimic hypomorphic mutations during early medaka embryogenesis.

Biology open·2025

Related Experiment Videos

A vital sugar code for ricin toxicity.

Jasmin Taubenschmid1, Johannes Stadlmann1, Markus Jost2

  • 1IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, VBC - Vienna BioCenter Campus, Dr. Bohr-Gasse 3, 1030 Vienna, Austria.

Cell Research
|September 20, 2017
PubMed
Summary

Scientists identified key regulators of ricin toxicity, showing that inhibiting fucosylation makes cells resistant to this deadly toxin. This discovery offers potential strategies against ricin bioweapons.

Related Experiment Videos

Area of Science:

  • Biochemistry
  • Cell Biology
  • Toxicology

Background:

  • Ricin is a highly toxic protein with no existing antidote, posing a significant bioweapon threat.
  • Understanding the molecular mechanisms of ricin toxicity is crucial for developing countermeasures.

Purpose of the Study:

  • To identify key molecular pathways regulating ricin toxicity.
  • To explore potential strategies for conferring cellular resistance to ricin.

Main Methods:

  • Genetic manipulation of fucosylation pathways (Slc35c1, Fut9).
  • Pharmacological inhibition of fucosylation.
  • Analysis of intracellular trafficking and cell surface glycan structures (Lewis X, sialylation).
  • Assessment of cell sensitivity to ricin exposure.

Main Results:

  • Inhibition of the Golgi GDP-fucose transporter (Slc35c1) and fucosyltransferase (Fut9) confers resistance to ricin.
  • Reduced fucosylation leads to increased sialylation of Lewis X, masking ricin-binding sites.
  • Cells with SLC35C1 deficiency are resistant to ricin.
  • Modulating sialyltransferase St3Gal4 affects ricin sensitivity.

Conclusions:

  • Fucosylation and sialylation pathways are critical regulators of ricin toxicity.
  • Targeting these glycosylation pathways offers a novel strategy to control ricin toxicity.
  • Insights into the 'sugar code' can be leveraged for biodefense applications.